Human Molecular Genetics Advance Access originally published online on December 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, 2004, Vol. 13, No. 3 353-361
DOI: 10.1093/hmg/ddh028
Developmentally regulated functions of the H19 differentially methylated domain
1Dipartimento di Scienze Ambientali, Seconda Università di Napoli, Caserta, Italy, 2GDPM Department, Institut Cochin, Paris, France, 3Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano, Università di Napoli Federico II, Napoli, Italy and 4Istituto di Endocrinologia ed Oncologia Sperimentale G. Salvatore, CNR, Napoli, Italy
Received October 20, 2003; Accepted December 1, 2003
Igf2 and H19 are physically linked imprinted genes. In embryonic liver, their reciprocal expression (paternal for Igf2 and maternal for H19) is controlled by a paternally methylated region (H19 DMD) located 5' of H19. This region contains a methylation-sensitive insulator that prevents the Igf2 promoters being activated by downstream enhancers on the maternal chromosome. In adult liver, Igf2 is normally not expressed but is reactivated upon tumour formation. By analysing three deletions of the H19 locus, we investigated the mechanism regulating the imprinted expression of the Igf2 gene in the course of liver tumourigenesis. We observed that the role of the H19 DMD in the control of Igf2 expression changes during tumourigenesis. The H19 DMD is required on the paternal chromosome for Igf2 activation in the early stages while its maternal allele is necessary for maintaining Igf2 imprinting only in the late stages. A positive regulatory function of the paternal H19 DMD is also evident in normal neonatal liver, but its relevance for Igf2 expression becomes higher in the second post-natal week. Our results support a model in which both methylated and non-methylated parental copies of the H19 DMD have active roles in the regulation of Igf2 expression in the liver and these activities are under developmental control.
* To whom correspondence should be addressed. Tel: +39 823274599; Fax: +39 823274605; Email: andrea.riccio{at}unina2.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Yoshimizu, A. Miroglio, M.-A. Ripoche, A. Gabory, M. Vernucci, A. Riccio, S. Colnot, C. Godard, B. Terris, H. Jammes, et al. The H19 locus acts in vivo as a tumor suppressor PNAS, August 26, 2008; 105(34): 12417 - 12422. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Tsang, T. W.L. Wong, A. H.H. Cheung, C. N.N. Co, and T. T. Kwok Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR RNA, June 1, 2007; 13(6): 890 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sparago, S. Russo, F. Cerrato, S. Ferraiuolo, P. Castorina, A. Selicorni, C. Schwienbacher, M. Negrini, G. B. Ferrero, M. C. Silengo, et al. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour Hum. Mol. Genet., February 1, 2007; 16(3): 254 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Engel, J. L. Thorvaldsen, and M. S. Bartolomei CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus Hum. Mol. Genet., October 1, 2006; 15(19): 2945 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Thorvaldsen, A. M. Fedoriw, S. Nguyen, and M. S. Bartolomei Developmental Profile of H19 Differentially Methylated Domain (DMD) Deletion Alleles Reveals Multiple Roles of the DMD in Regulating Allelic Expression and DNA Methylation at the Imprinted H19/Igf2 Locus Mol. Cell. Biol., February 15, 2006; 26(4): 1245 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Fellig, I Ariel, P Ohana, P Schachter, I Sinelnikov, T Birman, S Ayesh, T Schneider, N de Groot, A Czerniak, et al. H19 expression in hepatic metastases from a range of human carcinomas J. Clin. Pathol., October 1, 2005; 58(10): 1064 - 1068. [Abstract] [Full Text] [PDF] |
||||




